Greenlane Renewables, the biogas upgrading specialist, just released their Q1 2024 earnings transcript, and most analysts are focusing on the obvious: the company's continued push towards positive adjusted EBITDA and the refilling of their sales pipeline. While these are certainly important factors, there's a more subtle, yet potentially game-changing shift happening beneath the surface – one that could significantly alter Greenlane's future trajectory.

The key lies in Greenlane's strategic shift towards standardized products. Buried within Ian Kane's (<a href="https://www.greenlanerenewables.com/company/our-team/" alt="Ian Kane - President & CEO">President & CEO</a>) remarks is the statement: "We are transitioning from an engineered-to-order to a configured-to-order business model, emphasizing standard products to streamline our costs and enhance our competitiveness in the market." This isn't just corporate jargon; it's a fundamental change that speaks volumes about Greenlane's ambitions and understanding of the evolving RNG market.

Historically, Greenlane has focused on highly customized, engineered-to-order biogas upgrading systems. This approach, while allowing for tailored solutions, comes with inherent challenges: longer lead times, higher production costs, and a limited ability to scale quickly. The shift towards a configured-to-order model with standardized products addresses these challenges head-on.

Think of it like building a car. Engineered-to-order is akin to crafting a bespoke, one-of-a-kind vehicle. It's a meticulous process, but time-consuming and expensive. Configured-to-order, on the other hand, is like choosing a car model and then selecting from a set of predefined options – engine size, color, interior features. You still get a customized car, but the process is streamlined, faster, and more cost-effective.

This is precisely what Greenlane is doing. By creating a library of standardized components and systems, they can significantly reduce engineering and production costs. This, in turn, allows them to offer more competitive pricing, attract larger customers, and most importantly, scale their business rapidly to meet the growing demand for biogas upgrading solutions.

Implications of the Shift

The implications of this shift are profound:

<ul>

<li><strong>Capitalizing on Large-Scale Projects:</strong> It positions Greenlane to capitalize on the trend towards larger RNG projects, particularly in markets like Brazil and North America. Large-scale projects benefit immensely from standardized solutions, as they simplify design, construction, and maintenance.</li>

<li><strong>Predictable Revenue Stream:</strong> It creates a more predictable and consistent revenue stream. Standardized products, with shorter lead times, translate to faster revenue recognition and a more stable financial performance. This is a critical step for Greenlane in achieving its goal of consistent profitability.</li>

<li><strong>Enhanced Competitive Edge:</strong> It enhances Greenlane's competitive edge. By offering both cost-effective and scalable solutions, Greenlane is better equipped to compete with established players in the biogas upgrading market.</li>

</ul>

Unlocking Hidden Value in the ZEG Biogas Royalty Agreement

But the most compelling aspect of this strategic shift is its potential to unlock hidden value in Greenlane's <a href="https://www.greenlanerenewables.com/news-media/news-releases/greenlane-announces-collaboration-agreement-with-zeg-biogas-to-establish-industrial-scale-volume-production-in-brazil/" alt="Royalty Agreement with ZEG Biogas in Brazil">royalty agreement with ZEG Biogas in Brazil</a>. This agreement allows ZEG to manufacture Greenlane's biogas upgrading systems locally in Brazil under a royalty-based model.

Imagine combining ZEG's local manufacturing capacity with Greenlane's standardized product designs. This creates a powerful synergy: ZEG can rapidly produce and deploy standardized biogas upgrading systems throughout Brazil, a market teeming with potential, while Greenlane generates a recurring royalty stream on every unit sold.

Potential Royalty Revenue Scenario

Let's assume ZEG Biogas, leveraging Greenlane's standardized designs, ramps up production to sell 20 biogas upgrading units per year in Brazil. If each unit generates a royalty of $100,000 for Greenlane, that's a potential annual royalty revenue of $2 million.

This is just a hypothetical scenario, but it illustrates the transformative potential of Greenlane's strategic shift. It's a move that aligns perfectly with the maturing RNG market, unlocks hidden value in existing partnerships, and positions Greenlane for a future of sustainable growth and profitability. While the market is currently fixated on short-term metrics, those with a keen eye will recognize that Greenlane is quietly laying the foundation for a much bigger story – one that could rewrite the company's narrative and deliver substantial returns for investors.

"Fun Fact: Greenlane Renewables' biogas upgrading systems have helped prevent the release of millions of tons of CO2 equivalent into the atmosphere, making a significant contribution to combating climate change."